Drug Shortage Report for MULTAQ

Last updated on 2021-11-17 History
Report ID 142946
Drug Identification Number 02330989
Brand name MULTAQ
Common or Proper name Multaq
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) DRONEDARONE
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-07-24
Actual start date
Estimated end date 2021-11-30
Actual end date 2021-11-16
Shortage status Resolved
Updated date 2021-11-17
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-11-17 English Compare
v11 2021-11-16 French Compare
v10 2021-11-16 English Compare
v9 2021-11-10 French Compare
v8 2021-11-10 English Compare
v7 2021-08-26 French Compare
v6 2021-08-26 English Compare
v5 2021-07-29 French Compare
v4 2021-07-29 English Compare
v3 2021-07-25 English Compare
v2 2021-07-23 French Compare
v1 2021-07-23 English Compare

Showing 1 to 12 of 12